- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT04177914
HCRN Trattamento endoscopico rispetto allo shunt dell'idrocefalo nei neonati (ESTHI)
Trattamento endoscopico rispetto allo shunt dell'idrocefalo nei neonati
Hydrocephalus is a potentially debilitating neurological condition that primarily affects babies under a year of age and has traditionally been treated by inserting a shunt between the brain and the abdomen. A newer endoscopic procedure offers hope of shunt- free treatment that may reduce complications over a child's life, but it is not clear if the endoscopic procedure results in similar intellectual outcome as shunt. Therefore, the investigators propose a randomized trial to compare intellectual outcome and brain structural integrity between these two treatments, to help families make the best treatment decision for their baby.
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
The ESTHI Trial is a multi-center randomized controlled trial (RCT) comparing endoscopic third ventriculostomy with choroid plexus cauterization (ETV+CPC) and shunt in infants with hydrocephalus. The study will leverage the infrastructure of the Hydrocephalus Clinical Research Network (HCRN), a committed group of 14 leading North American pediatric neurosurgical centers with a long track-record of successful collaborative clinical research and RCTs in hydrocephalus. Optimal cognitive outcome is the primary concern of families and will, therefore, be the primary outcome. Assessment of dMRI, a validated, non-invasive method of measuring white matter microstructural integrity and structural connectivity in the developing brain, will provide further insight into the developmental consequences of these two treatments. The results of the RCT will help families determine the optimal treatment of hydrocephalus for their child.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Alberta
-
Calgary, Alberta, Canada, T3B 6A8
- Alberta Children's Hospital
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6H 3V4
- British Columbia Children's Hospital
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X8
- The Hospital for Sick Children
-
-
-
-
Alabama
-
Birmingham, Alabama, Stati Uniti, 35233
- Children's of Alabama
-
-
Arizona
-
Phoenix, Arizona, Stati Uniti, 85016
- Phoenix Children's Hospital
-
-
California
-
Los Angeles, California, Stati Uniti, 90027
- Children's Hospital of Los Angeles
-
-
Colorado
-
Aurora, Colorado, Stati Uniti, 80045
- Children's Hospital Colorado
-
-
Connecticut
-
New Haven, Connecticut, Stati Uniti, 06520
- Yale University
-
-
Florida
-
Jacksonville, Florida, Stati Uniti, 32207
- Wolfson Children's Hospital
-
Orlando, Florida, Stati Uniti, 32806
- Arnold Palmer Hospital for Children
-
-
Indiana
-
Indianapolis, Indiana, Stati Uniti, 46202
- Trustees of Indiana University
-
-
Maryland
-
Baltimore, Maryland, Stati Uniti, 21287
- Johns Hopkins Children's Center
-
-
Missouri
-
St Louis, Missouri, Stati Uniti, 63110
- St. Louis Children's Hospital
-
-
Ohio
-
Columbus, Ohio, Stati Uniti, 43205
- Nationwide Children's Hospital
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, Stati Uniti, 15224
- Children's Hospital of Pittsburgh of UPMC
-
University Park, Pennsylvania, Stati Uniti, 16802
- The Pennsylvania State University
-
-
Tennessee
-
Nashville, Tennessee, Stati Uniti, 37232
- Monroe Carell Jr. Children's Hospital at Vanderbilt
-
-
Texas
-
Houston, Texas, Stati Uniti, 77030
- Texas Children's Hospital
-
-
Utah
-
Salt Lake City, Utah, Stati Uniti, 84118
- Primary Children's Hospital
-
-
Virginia
-
Richmond, Virginia, Stati Uniti, 23284
- Virginia Commonwealth University
-
-
Washington
-
Seattle, Washington, Stati Uniti, 98105
- Seattle Children's Hospital
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
-
Corrected age <104 weeks and 0 days,
AND
-
Child is ≥ 37 weeks post menstrual age,
AND
-
Child must have symptomatic hydrocephalus, defined as:
Ventriculomegaly on MRI (frontal-occipital horn ratio (FOR) >0.45, which approximates "moderate ventriculomegaly"), and at least one of the following:
- Head circumference >98th percentile for corrected age with either bulging fontanelle or splayed sutures
- Upgaze paresis/palsy (sundowning)
- CSF leak
- Papilledema
- Tense pseudomeningocele or tense fluid along a track
- Vomiting or irritability, with no other attributable cause
- Bradycardias or apneas, with no other attributable cause
- Intracranial pressure (ICP) monitoring showing persistent elevation of pressure with or without plateau waves
AND
-
No prior history of shunt insertion or endoscopic third ventriculostomy (ETV) procedure (previous temporization devices and/or external ventricular drains permissible)
Exclusion Criteria:
-
Hydrocephalus due to intraventricular hemorrhage in a child born before 37 weeks gestational age; OR
-
Anatomy not suitable for ETV+CPC or anteriorly placed ventriculoperitoneal shunt defined as:
- Moderate to severe prepontine adhesions on steady state free precession (SSFP) or T2 weighted fast (turbo) spin echo (FSE/TSE) MRI, which includes the following sequences: FIESTA, FIESTA-C, TrueFISP, CISS, Balanced FFE (bFFE), CUBE, SPACE, VISTA, IsoFSE, and 3D MVOX
- Closure of one or both foramina of Monro
- Thick floor of third ventricle (≥ 3mm)
- Narrow third ventricle (<5mm)
- Presence of scalp, bone, or ventricular lesions that make placement of an anterior shunt impracticable; OR
-
Underlying condition with a high chance of mortality within 12 months; OR
-
Hydrocephalus with loculated CSF compartments; OR
-
Peritoneal cavity not suitable for distal shunt placement; OR
-
Active CSF infection; OR
-
Hydranencephaly; OR
-
Child requires an intraventricular procedure (e.g. endoscopic biopsy) in addition to the initial first-time permanent procedure for the treatment of hydrocephalus.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: ETV+CPC
Subjects randomized to this arm will undergo an ETV+CPC procedure for treatment of Hydrocephalus |
Since the early 1990s, ETV has become the main alternative to shunting for hydrocephalus. This procedure involves placing an endoscopic camera into the ventricles of the brain and creating a hole in the floor of the third ventricle to act as an internal bypass for obstructed CSF. The cauterization of choroid plexus (CPC) involves the use of a device to burn or cauterize tissue from the choroid plexus. The choroid plexus of the brain exists in the lateral ventricles, the third ventricle, and the fourth ventricle. Its main role is the production of CSF. The success of ETV alone is poor in infants, but when combined with CPC, improved results have been observed and ETV+CPC has become a safe viable option for these children. |
|
Comparatore attivo: Ventriculoperitoneal Shunt
Subjects randomized to this arm will undergo a Ventriculoperitoneal Shunt procedure for treatment of Hydrocephalus |
The most common treatment for hydrocephalus has been the insertion of a ventriculoperitoneal shunt, which has been in popular use for over 50 years. This consists of silastic tubing attached to a valve mechanism that runs subcutaneously from the head to the abdomen. It is one of the most common procedures performed by pediatric neurosurgeons. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Bayley Scale of Infant Development-IV (Bayley-IV) Cognitive Scale score
Lasso di tempo: 12 months post randomized surgical intervention
|
The primary objective is to determine, in infants <104 weeks corrected age, with hydrocephalus requiring treatment at tertiary care pediatric neurosurgery centers in North America, if treatment with ETV+CPC compared to shunt results in non-inferior cognitive outcome at 12 months from surgery, as measured by Bayley-IV Cognitive Scale score with a non-inferiority margin of 1.5. Scaled scores range from 1-19. Higher scores indicate better outcomes. Scores will also be obtained at 3 and 5 years of age. |
12 months post randomized surgical intervention
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Bayley Scale of Infant Development-IV (Bayley-IV) Language Scaled Score
Lasso di tempo: 12 months post randomized surgical intervention
|
To determine, in the same cohort of infants, if ETV+CPC compared to shunt results in non-inferior Bayley-IV Language Scaled scores. Scaled scores range from 1-19. Higher scores indicate better outcomes. |
12 months post randomized surgical intervention
|
|
Bayley Scale of Infant Development-IV (Bayley-IV) Motor Scaled Score
Lasso di tempo: 12 months post randomized surgical intervention
|
To determine, in the same cohort of infants, if ETV+CPC compared to shunt results in non-inferior Bayley-IV Motor Scaled scores. Scaled scores range from 1-19. Higher scores indicate better outcomes. |
12 months post randomized surgical intervention
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Vineland-3 Communication Domain Score
Lasso di tempo: 12 months post randomized surgical intervention
|
To determine, in the same cohort of infants, if ETV+CPC compared to shunt results in non-inferior Vineland-3 Communication Domain scores. Domain scores range from 20-140. Higher scores indicate better outcomes. |
12 months post randomized surgical intervention
|
|
Vineland-3 Daily Living Skills Domain Score
Lasso di tempo: 12 months post randomized surgical intervention
|
To determine, in the same cohort of infants, if ETV+CPC compared to shunt results in non-inferior Vineland-3 Daily Living Skills Domain scores. Domain scores range from 20-140. Higher scores indicate better outcomes. |
12 months post randomized surgical intervention
|
|
Vineland-3 Socialization Domain Score
Lasso di tempo: 12 months post randomized surgical intervention
|
To determine, in the same cohort of infants, if ETV+CPC compared to shunt results in non-inferior Vineland-3 Socialization Domain scores. Domain scores range from 20-140. Higher scores indicate better outcomes. |
12 months post randomized surgical intervention
|
|
Vineland-3 Motor Skills Domain Score
Lasso di tempo: 12 months post randomized surgical intervention
|
To determine, in the same cohort of infants, if ETV+CPC compared to shunt results in non-inferior Vineland-3 Motor Skills Domain scores. Domain scores range from 20-140. Higher scores indicate better outcomes. |
12 months post randomized surgical intervention
|
|
Vineland-3 Adaptive Behavior Composite Score
Lasso di tempo: 12 months post randomized surgical intervention
|
To determine, in the same cohort of infants, if ETV+CPC compared to shunt results in non-inferior Vineland-3 Adaptive Behavior Composite (ABC) scores. ABC scores range from 20-140. Higher scores indicate better outcomes. |
12 months post randomized surgical intervention
|
|
The occurrence of treatment failure.
Lasso di tempo: Through study completion, a maximum of 7 years.
|
Treatment failure is defined as obstruction, loculated compartments, overdrainage, CSF infection, or significant intraoperative complication. The rate of occurrence of each type, for the initial procedure, will be calculated. Failure can be captured at anytime during the course of the 7 year study. Occurrence between treatment arms will be compared. |
Through study completion, a maximum of 7 years.
|
|
Time to failure.
Lasso di tempo: Through study completion, a maximum of 7 years
|
Time to failure is the number of days in which the intervention is functionally successful. It is calculated from date of surgery to date of failure, as described in Outcome 9. Time to failure between treatment arms will be compared. |
Through study completion, a maximum of 7 years
|
|
Total number of hospital admission days within 12 months after surgery
Lasso di tempo: 12 months post randomized surgical intervention
|
Number of days subject is admitted to the hospital during the first 12 months following the initial surgical intervention. All hospital admissions included, regardless of reason for admission. Number of hospital admission days between treatment arms will be compared. |
12 months post randomized surgical intervention
|
|
Total number of repeat surgeries within 12 months after surgery
Lasso di tempo: 12 months post randomized surgical intervention
|
Number of shunt and ETV+CPC procedures during the first 12 months following the initial surgical intervention. Number of repeat surgeries between treatment arms will be compared. |
12 months post randomized surgical intervention
|
|
Total number of brain imaging (CT, MRI, ultrasound) scans within 12 months after surgery
Lasso di tempo: 12 months post randomized surgical intervention
|
Number of CT, MRI, and ultrasound brain scans during the first 12 months following the initial surgical intervention. Total imaging between treatment arms will be compared. |
12 months post randomized surgical intervention
|
|
All major peri-operative and post-operative complications
Lasso di tempo: Through study completion, a maximum of 7 years
|
Number of peri-operative and post-operative complications to include those related to CSF circulation, infection, hemorrhage, seizures, and new neurological deficits. Number of complications between treatment arms will be compared. |
Through study completion, a maximum of 7 years
|
|
Brain and ventricle volume on MRI performed at 12 months after surgery
Lasso di tempo: 12 months post randomized surgical intervention
|
Brain and CSF volumes will be converted to Z-scores based on previously described age- and sex-adjusted distributions and used for comparison of brain volume and growth between ETV+CPC and shunt treatment groups. |
12 months post randomized surgical intervention
|
|
dMRI corpus collosum (CC) and corticospinal tract (CST) fractional anisotropy (FA) at 12 months after surgery.
Lasso di tempo: 12 months post randomized surgical intervention
|
Develop dMRI maps, including fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD). Tract-based spatial statistics (TBSS) will be used for voxel-wise analyses of white matter tracts. Maps will be used to compare cerebral structural connectivity between the two treatment arms. |
12 months post randomized surgical intervention
|
|
Cerebral spinal fluid myelin basic protein (MBP) levels measured at the time of ETV+CPC or shunt
Lasso di tempo: 12 months post randomized surgical intervention
|
Examine correlations of cerebral spinal fluid myelin basic protein (MBP) levels to post-operative Bayley-IV Cognitive Scale score. |
12 months post randomized surgical intervention
|
|
Cerebral spinal fluid amyloid precursor protein (APP) levels measured at the time of ETV+CPC or shunt
Lasso di tempo: 12 months post randomized surgical intervention
|
Examine correlations of cerebral spinal fluid amyloid precursor protein (APP) to post-operative Bayley-IV Cognitive Scale score |
12 months post randomized surgical intervention
|
|
Cerebral spinal fluid NCAM-1 levels measured at the time of ETV+CPC or shunt
Lasso di tempo: 12 months post randomized surgical intervention
|
Examine correlations of cerebral spinal fluid NCAM-1 levels to post-operative Bayley-IV Cognitive Scale score |
12 months post randomized surgical intervention
|
|
Cerebral spinal fluid glial fibrillary acid protein (GFAP) levels measured at the time of ETV+CPC or shunt
Lasso di tempo: 12 months post randomized surgical intervention
|
Examine correlations of cerebral spinal fluid glial fibrillary acid protein (GFAP) to post-operative Bayley-IV Cognitive Scale score |
12 months post randomized surgical intervention
|
|
Wechsler Preschool & Primary Scale of Intelligence (WPPSI) Scores
Lasso di tempo: At 5 years of age
|
To determine, in infants who reach 5 years of age before the end of the study, if ETV+CPC compared to shunt results in non-inferior WPPSI scaled scores. Scaled scores range from 1-19. Higher scores indicate better outcomes. |
At 5 years of age
|
|
Health related quality of life (HRQoL) measurements
Lasso di tempo: 12 months post randomized surgical intervention, and at 3 and 5 years of age
|
To compare health-related quality of life (HRQoL), as measured by vi-sual analogue scales (VAS), Health Utilities Preschool (HuPS), and the Hydrocephalus Outcome Questionnaire (HOQ), between treatment arms. |
12 months post randomized surgical intervention, and at 3 and 5 years of age
|
Collaboratori e investigatori
Sponsor
Collaboratori
Investigatori
- Cattedra di studio: John Kestle, MD, University of Utah
- Investigatore principale: Abhaya Kulkarni, MD, University of Toronto
- Investigatore principale: David Limbrick, MD, Washington University School of Medicine
- Investigatore principale: Richard Holubkov, PhD, University of Utah
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- HCRN 012
- 1U01NS107486-01A1 (Sovvenzione/contratto NIH degli Stati Uniti)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
After subject enrollment and 5 year follow up have been completed, we will prepare a final study database for analysis. A releasable database will be produced and completely de-identified in accordance with the definitions provided in the Health insurance Portability and Accountability Act (HIPAA). Namely, all identifiers specified in HIPAA will be recoded in a manner that will make it impossible to deduce or impute the specific identity of any patient. The database will not contain any institutional identifiers. We will also prepare a data dictionary that provides a concise definition of every data element included in the database. If specific data elements have idiosyncrasies that might affect interpretation or analysis, this will be discussed in the dictionary document.
In accordance with policies determined by the investigators and funding sponsors, the releasable database will be provided to users in electronic form.
Periodo di condivisione IPD
Within one year of primary publication or within 18 months of the last study visit of the last subject, whichever occurs first.
Tipo di informazioni di supporto alla condivisione IPD
- STUDIO_PROTOCOLLO
- LINFA
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .